OP7H:PA:PA-Ossiam Bloomberg USA PAB UCITS ETF - 1A EUR Hedged Acc (EUR)

ETF | Others |

Last Closing

USD 139.2573

Change

-2.21 (-1.57)%

Market Cap

N/A

Volume

317.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.20 (+0.44%)

USD 61.38B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+4.40 (+0.77%)

USD 13.43B
WRD:PA HSBC MSCI World UCITS ETF

+0.27 (+0.76%)

USD 11.05B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+3.57 (+0.88%)

USD 9.62B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.25 (-0.11%)

USD 8.55B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+4.50 (+0.89%)

USD 8.53B
HHH:PA HSBC S&P 500 UCITS ETF

+0.46 (+0.79%)

USD 7.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

+3.17 (+0.89%)

USD 7.63B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.17 (+0.88%)

USD 6.83B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+1.58 (+0.97%)

USD 5.48B

ETFs Containing OP7H:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.48% 74% C 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.48% 73% C 80% B-
Trailing 12 Months  
Capital Gain 21.52% 72% C 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.52% 72% C 79% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.88% 52% F 58% F
Dividend Return 7.88% 50% F 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.23% 56% F 94% A
Risk Adjusted Return 64.42% 47% F 70% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.